Milestones & Recognition
Only what can be sourced
Every entry on this page corresponds to a publicly reported event. Nothing has been added to lengthen the list, and where reports differ on a date, the discrepancy is stated rather than smoothed over.
Era one
1976
–1996
The company that would later be led. Foundation, industrial firsts, and the technical direction that shaped everything after.
Era two
1997
–2018
Entry, statutory accountability, operating leadership — and the listing that changed what the company had to disclose.
Era three
2019
→
The chairmanship, and the six years that followed.
-
2019 — announced January 2020
Appointed Chairwoman of the Board and Chief Executive Officer
The board appoints her to succeed founder Omar Tazi, who takes the chair of a newly created strategic committee tasked with defining and monitoring the group’s strategic orientations. Forbes Middle East and World Bank Live record 2019 as the year she assumed the role; the Moroccan pharmaceutical press reported the handover in January 2020.
-
2020–2021
Pandemic response
The group reports having maintained all customer orders despite acute global supply pressure. Sothema was involved in securing vaccine supply for Morocco and conducted preliminary clinical work in connection with Sinopharm’s anti-COVID vaccines.
-
September 2021
Elected Vice-President General of the FMIIP
Elected for a three-year mandate to the Moroccan Federation of the Pharmaceutical Industry and Innovation, alongside President Mohamed El Bouhmadi. She had previously served as Vice-President of the Moroccan Association of the Pharmaceutical Industry (AMIP), and sits on the executive bureau of the Moroccan Association of Exporters (ASMEX).
-
June 2023
Galenic development and clinical trials platform
Sothema partners with Baylor College of Medicine, Dassault Systèmes, ReGenLab and Moroccan government ministries to establish what is announced as the first platform of its kind in Africa and the Middle East.
-
October 2023
Scientific office opened in Saudi Arabia
Extending the group’s technical and regulatory presence in the Gulf.
-
November 2024
New storage facility
Opened at a reported investment of approximately 20 million US dollars.
-
July 2025
Agreement to acquire Soludia Maghreb
An agreement to acquire 99.99% of the capital of Soludia Maghreb, a leading Moroccan industrial player in haemodialysis founded in 1996, at an enterprise value of approximately one billion Moroccan dirhams — close to 111 million US dollars. Following the transaction the group indicated consolidated 2025 revenue of around 3.5 billion dirhams and consolidated EBITDA above 800 million.
Recognition
Listings and regional recognition
Independent rankings compiled by Forbes Middle East, and institutional recognition of her role in the sector.
| Year | Recognition | Detail |
|---|---|---|
| 2022 | Forbes Middle East — Top 50 Leaders Transforming Healthcare | Regional healthcare leadership ranking |
| 2023 | Forbes Middle East — Top 100 Healthcare Leaders | Regional healthcare leadership ranking |
| 2024 | Forbes Middle East — 100 Most Powerful Businesswomen | Regional ranking of businesswomen |
| 2025 | Forbes Middle East — 100 Most Powerful Businesswomen | Ranked 33rd |
| 2025 | Forbes Middle East — Top Healthcare Leaders, Founders & Shareholders | Ranked 24th |
| Ongoing | Vice-President General, FMIIP | Elected September 2021 for a three-year mandate |
| Ongoing | Board member, CGEM | General Confederation of Moroccan Enterprises |
| Ongoing | Executive bureau, ASMEX | Moroccan Association of Exporters |
A note on what is not listed here
Some coverage of Lamia Tazi refers in general terms to “numerous accolades and awards” without naming them. Those references are not reproduced on this page. An unnamed award is not a verifiable one, and listing it would inflate the record without informing the reader.
Similarly, this website makes no claim about her personal wealth. Financial journalism has at times covered movements in the value of her shareholding; those are market events rather than professional achievements, and they belong to a different kind of publication. Where a figure appears anywhere on this site, it is a company figure with its source named.